Company / R&D per Share
Cocrystal Pharma, Inc. R&D per Share History
FY2012-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.12
FY2021
5-year range
$0.01 / $0.16
FY2017-FY2021
Trend
+9.6%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.16 to $0.12 over the past 2 years.
Based on SEC 10-K filings.
0.12 in FY2021.
Declined from $0.16 to $0.12 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, r&d per share increased 9.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score 14.87 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2021 | $0.12 | +9.6% |
| FY2020 | $0.11 | -26.9% |
| FY2019 | $0.16 | +1657.9% |
| FY2012 | $0.01 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026